Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Combined With LC Bead-TACE for HCC
NCT00844883Phase 2Completed
- Sponsor
- Yale University
- Start
- Feb 2009
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Yale University. Started Feb 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00844883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844883.